Central Garden & Pet/$CENTA

1D1W1MYTD1Y5YMAX

About Central Garden & Pet

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.
Ticker
$CENTA
Primary listing
NASDAQ
Employees
5,850

CENTA Metrics

BasicAdvanced
$2.2B
12.95
$2.67
0.54
-

What the Analysts think about CENTA

Analyst ratings (Buy, Hold, Sell) for Central Garden & Pet stock.
Analyst projections of the future price of Central Garden & Pet stock.

Bulls say / Bears say

Underlying demand improved in both divisions: third-quarter organic sales rose 2%, while gross margin expanded to 35.9% and non-GAAP operating margin reached 15.4%. Central responded by raising fiscal 2026 adjusted EPS guidance to at least $2.85. (SEC filing, Nasdaq)
The company has meaningful financial flexibility for investment: cash was close to $1 billion and net leverage was only 0.5 times after the third quarter. That gives Central room to fund growth deals, buybacks or productivity projects without relying heavily on new borrowing. (SEC filing, StockAnalysis)
The planned purchase of 80% of TRIXIE could broaden Central beyond the US and add a higher-margin European pet platform. Management says the deal should be margin-accretive, with further potential from stronger e-commerce, sourcing and innovation. (ADVFN, EarningsCalls)
Reported sales fell 8% in the latest quarter and earnings per share also declined year on year. The pet-distribution exit explains much of the drop, but lower Dog and Cat revenue and the resulting revenue comparisons could keep the headline growth rate weak for several quarters. (Longbridge, EarningsCalls)
TRIXIE brings execution and financing risk: Central will pay €340 million upfront, with consideration of up to €400 million, yet the acquired business has suffered low-single-digit sales declines in recent years. The deal is also excluded from current fiscal 2026 guidance and is not expected to close until the first half of fiscal 2027. (ADVFN, EarningsCalls)
The improved profit outlook still assumes a competitive, promotional retail market, a value-focused consumer, existing tariffs and inflation in selected commodities. These pressures could limit pricing power and make recent margin gains less durable, which helps explain why some analysts remain cautious or underweight on the shares. (Stockhouse, MarketBeat)
Data summarised monthly by Lightyear AI. Last updated on 19 Sept 2026.

CENTA Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

CENTA Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing CENTA

AllUSDGBPEUR
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.